Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study (Q77628536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

myelodysplastic syndrome

1 reference

Deeg HJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Gotlib J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Beckham C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Dugan K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Holmberg L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Schubert M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Appelbaum F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Greenberg P

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

162-164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11840280%20AND%20SRC:MED&resulttype=core&format=json

Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021

Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402356

7 January 2021